Global Oxycodone Hydrochloride Injection Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11245582

Publication Date:

November 12, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Oxycodone Hydrochloride Injection is a strong opioid analgesic used to relieve moderate to severe pain. Its main ingredient is oxycodone hydrochloride, a semi-synthetic opioid receptor agonist with a strong analgesic effect.
The global Oxycodone Hydrochloride Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (publisher)' newest research report, the 鈥淥xycodone Hydrochloride Injection Industry Forecast鈥� looks at past sales and reviews total world Oxycodone Hydrochloride Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Oxycodone Hydrochloride Injection sales for 2023 through 2029. With Oxycodone Hydrochloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oxycodone Hydrochloride Injection industry.
This Insight Report provides a comprehensive analysis of the global Oxycodone Hydrochloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oxycodone Hydrochloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Oxycodone Hydrochloride Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oxycodone Hydrochloride Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oxycodone Hydrochloride Injection.
United States market for Oxycodone Hydrochloride Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oxycodone Hydrochloride Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oxycodone Hydrochloride Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oxycodone Hydrochloride Injection players cover Sumitomo Pharma America, Inc., NAPP PHARMACEUTICALS LIMITED, Teva Takeda Yakuhin Ltd., LTL Pharma Co., Ltd., Mylan Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oxycodone Hydrochloride Injection market by product type, application, key players and key regions and countries.
Segmentation by Type:
2ml:20mg
1ml:10mg
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
2ml:20mg
1ml:10mg
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sumitomo Pharma America, Inc.
NAPP PHARMACEUTICALS LIMITED
Teva Takeda Yakuhin Ltd.
LTL Pharma Co., Ltd.
Mylan Pharmaceuticals
Organon LLC
Santen Pharmaceutical Co.,Ltd.
Hengrui Medicine
Teva Pharmaceutical Industries

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oxycodone Hydrochloride Injection Market Size 2019-2030
2.1.2 Oxycodone Hydrochloride Injection Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Oxycodone Hydrochloride Injection by Country/Region, 2019, 2023 & 2030
2.2 Oxycodone Hydrochloride Injection Segment by Type
2.2.1 2ml:20mg
2.2.2 1ml:10mg
2.3 Oxycodone Hydrochloride Injection Market Size by Type
2.3.1 Oxycodone Hydrochloride Injection Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oxycodone Hydrochloride Injection Market Size Market Share by Type (2019-2024)
2.4 Oxycodone Hydrochloride Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Oxycodone Hydrochloride Injection Market Size by Application
2.5.1 Oxycodone Hydrochloride Injection Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oxycodone Hydrochloride Injection Market Size Market Share by Application (2019-2024)
3 Oxycodone Hydrochloride Injection Market Size by Player
3.1 Oxycodone Hydrochloride Injection Market Size Market Share by Player
3.1.1 Global Oxycodone Hydrochloride Injection Revenue by Player (2019-2024)
3.1.2 Global Oxycodone Hydrochloride Injection Revenue Market Share by Player (2019-2024)
3.2 Global Oxycodone Hydrochloride Injection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oxycodone Hydrochloride Injection by Region
4.1 Oxycodone Hydrochloride Injection Market Size by Region (2019-2024)
4.2 Global Oxycodone Hydrochloride Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oxycodone Hydrochloride Injection Market Size Growth (2019-2024)
4.4 APAC Oxycodone Hydrochloride Injection Market Size Growth (2019-2024)
4.5 Europe Oxycodone Hydrochloride Injection Market Size Growth (2019-2024)
4.6 Middle East & Africa Oxycodone Hydrochloride Injection Market Size Growth (2019-2024)
5 Americas
5.1 Americas Oxycodone Hydrochloride Injection Market Size by Country (2019-2024)
5.2 Americas Oxycodone Hydrochloride Injection Market Size by Type (2019-2024)
5.3 Americas Oxycodone Hydrochloride Injection Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oxycodone Hydrochloride Injection Market Size by Region (2019-2024)
6.2 APAC Oxycodone Hydrochloride Injection Market Size by Type (2019-2024)
6.3 APAC Oxycodone Hydrochloride Injection Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oxycodone Hydrochloride Injection Market Size by Country (2019-2024)
7.2 Europe Oxycodone Hydrochloride Injection Market Size by Type (2019-2024)
7.3 Europe Oxycodone Hydrochloride Injection Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oxycodone Hydrochloride Injection by Region (2019-2024)
8.2 Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Type (2019-2024)
8.3 Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Oxycodone Hydrochloride Injection Market Forecast
10.1 Global Oxycodone Hydrochloride Injection Forecast by Region (2025-2030)
10.1.1 Global Oxycodone Hydrochloride Injection Forecast by Region (2025-2030)
10.1.2 Americas Oxycodone Hydrochloride Injection Forecast
10.1.3 APAC Oxycodone Hydrochloride Injection Forecast
10.1.4 Europe Oxycodone Hydrochloride Injection Forecast
10.1.5 Middle East & Africa Oxycodone Hydrochloride Injection Forecast
10.2 Americas Oxycodone Hydrochloride Injection Forecast by Country (2025-2030)
10.2.1 United States Market Oxycodone Hydrochloride Injection Forecast
10.2.2 Canada Market Oxycodone Hydrochloride Injection Forecast
10.2.3 Mexico Market Oxycodone Hydrochloride Injection Forecast
10.2.4 Brazil Market Oxycodone Hydrochloride Injection Forecast
10.3 APAC Oxycodone Hydrochloride Injection Forecast by Region (2025-2030)
10.3.1 China Oxycodone Hydrochloride Injection Market Forecast
10.3.2 Japan Market Oxycodone Hydrochloride Injection Forecast
10.3.3 Korea Market Oxycodone Hydrochloride Injection Forecast
10.3.4 Southeast Asia Market Oxycodone Hydrochloride Injection Forecast
10.3.5 India Market Oxycodone Hydrochloride Injection Forecast
10.3.6 Australia Market Oxycodone Hydrochloride Injection Forecast
10.4 Europe Oxycodone Hydrochloride Injection Forecast by Country (2025-2030)
10.4.1 Germany Market Oxycodone Hydrochloride Injection Forecast
10.4.2 France Market Oxycodone Hydrochloride Injection Forecast
10.4.3 UK Market Oxycodone Hydrochloride Injection Forecast
10.4.4 Italy Market Oxycodone Hydrochloride Injection Forecast
10.4.5 Russia Market Oxycodone Hydrochloride Injection Forecast
10.5 Middle East & Africa Oxycodone Hydrochloride Injection Forecast by Region (2025-2030)
10.5.1 Egypt Market Oxycodone Hydrochloride Injection Forecast
10.5.2 South Africa Market Oxycodone Hydrochloride Injection Forecast
10.5.3 Israel Market Oxycodone Hydrochloride Injection Forecast
10.5.4 Turkey Market Oxycodone Hydrochloride Injection Forecast
10.6 Global Oxycodone Hydrochloride Injection Forecast by Type (2025-2030)
10.7 Global Oxycodone Hydrochloride Injection Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Oxycodone Hydrochloride Injection Forecast
11 Key Players Analysis
11.1 Sumitomo Pharma America, Inc.
11.1.1 Sumitomo Pharma America, Inc. Company Information
11.1.2 Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Product Offered
11.1.3 Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sumitomo Pharma America, Inc. Main Business Overview
11.1.5 Sumitomo Pharma America, Inc. Latest Developments
11.2 NAPP PHARMACEUTICALS LIMITED
11.2.1 NAPP PHARMACEUTICALS LIMITED Company Information
11.2.2 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Product Offered
11.2.3 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 NAPP PHARMACEUTICALS LIMITED Main Business Overview
11.2.5 NAPP PHARMACEUTICALS LIMITED Latest Developments
11.3 Teva Takeda Yakuhin Ltd.
11.3.1 Teva Takeda Yakuhin Ltd. Company Information
11.3.2 Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Product Offered
11.3.3 Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Teva Takeda Yakuhin Ltd. Main Business Overview
11.3.5 Teva Takeda Yakuhin Ltd. Latest Developments
11.4 LTL Pharma Co., Ltd.
11.4.1 LTL Pharma Co., Ltd. Company Information
11.4.2 LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Product Offered
11.4.3 LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 LTL Pharma Co., Ltd. Main Business Overview
11.4.5 LTL Pharma Co., Ltd. Latest Developments
11.5 Mylan Pharmaceuticals
11.5.1 Mylan Pharmaceuticals Company Information
11.5.2 Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Product Offered
11.5.3 Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Mylan Pharmaceuticals Main Business Overview
11.5.5 Mylan Pharmaceuticals Latest Developments
11.6 Organon LLC
11.6.1 Organon LLC Company Information
11.6.2 Organon LLC Oxycodone Hydrochloride Injection Product Offered
11.6.3 Organon LLC Oxycodone Hydrochloride Injection Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Organon LLC Main Business Overview
11.6.5 Organon LLC Latest Developments
11.7 Santen Pharmaceutical Co.,Ltd.
11.7.1 Santen Pharmaceutical Co.,Ltd. Company Information
11.7.2 Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Product Offered
11.7.3 Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Santen Pharmaceutical Co.,Ltd. Main Business Overview
11.7.5 Santen Pharmaceutical Co.,Ltd. Latest Developments
11.8 Hengrui Medicine
11.8.1 Hengrui Medicine Company Information
11.8.2 Hengrui Medicine Oxycodone Hydrochloride Injection Product Offered
11.8.3 Hengrui Medicine Oxycodone Hydrochloride Injection Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Hengrui Medicine Main Business Overview
11.8.5 Hengrui Medicine Latest Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Information
11.9.2 Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Product Offered
11.9.3 Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Pharmaceutical Industries Main Business Overview
11.9.5 Teva Pharmaceutical Industries Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂